184 related articles for article (PubMed ID: 8940714)
1. PET and [18F]-FDG in oncology: a clinical update.
Conti PS; Lilien DL; Hawley K; Keppler J; Grafton ST; Bading JR
Nucl Med Biol; 1996 Aug; 23(6):717-35. PubMed ID: 8940714
[TBL] [Abstract][Full Text] [Related]
2. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
Brock CS; Meikle SR; Price P
Eur J Nucl Med; 1997 Jun; 24(6):691-705. PubMed ID: 9169580
[TBL] [Abstract][Full Text] [Related]
3. PET FDG studies in oncology.
Hawkins RA; Hoh CK
Nucl Med Biol; 1994 Jul; 21(5):739-47. PubMed ID: 9241650
[TBL] [Abstract][Full Text] [Related]
4. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.
Rigo P; Paulus P; Kaschten BJ; Hustinx R; Bury T; Jerusalem G; Benoit T; Foidart-Willems J
Eur J Nucl Med; 1996 Dec; 23(12):1641-74. PubMed ID: 8929320
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography in oncology.
Leskinen-Kallio S
Clin Physiol; 1994 May; 14(3):329-35. PubMed ID: 8026150
[TBL] [Abstract][Full Text] [Related]
6. [Cancer diagnosis with positron emission tomography (PET)].
Kubota K
Kaku Igaku; 1996 Feb; 33(2):207-12. PubMed ID: 8721109
[TBL] [Abstract][Full Text] [Related]
7. Use of positron emission tomography in oncology.
Glaspy JA; Hawkins R; Hoh CK; Phelps ME
Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of early cancer with positron emission tomography].
Kubota K
Nihon Rinsho; 1996 May; 54(5):1263-7. PubMed ID: 8965348
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis of cancers by FDG-PET].
Ichiya Y
Fukuoka Igaku Zasshi; 1997 Jan; 88(1):7-10. PubMed ID: 9091463
[No Abstract] [Full Text] [Related]
10. [Potential use of positron-emission tomography in clinical oncology].
Fukuda H; Matsuzawa T; Tateno Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):860-5. PubMed ID: 3291774
[TBL] [Abstract][Full Text] [Related]
11. PET scans of abdominal malignancy.
Blahd WH; Brown CV; Khonsary SA; Farahi JB; Quinones N; Ribe JY; Coyle JJ; Glass EC; Mandelkern MA
World J Surg; 1996 Feb; 20(2):245-7. PubMed ID: 8661826
[TBL] [Abstract][Full Text] [Related]
12. Is there a future for PET in oncology?
Price P
Eur J Nucl Med; 1997 Jun; 24(6):587-9. PubMed ID: 9235296
[No Abstract] [Full Text] [Related]
13. PET cancer evaluations with FDG.
Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
[No Abstract] [Full Text] [Related]
14. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.
Lai DT; Fulham M; Stephen MS; Chu KM; Solomon M; Thompson JF; Sheldon DM; Storey DW
Arch Surg; 1996 Jul; 131(7):703-7. PubMed ID: 8678767
[TBL] [Abstract][Full Text] [Related]
15. Cancer detection with whole-body PET using 2-[18F]fluoro-2-deoxy-D-glucose.
Hoh CK; Hawkins RA; Glaspy JA; Dahlbom M; Tse NY; Hoffman EJ; Schiepers C; Choi Y; Rege S; Nitzsche E
J Comput Assist Tomogr; 1993; 17(4):582-9. PubMed ID: 8331230
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography in oncology: the most sophisticated imaging technology.
Lacić M; Maisey MN; Kusić Z
Acta Med Croatica; 1997; 51(1):1-9. PubMed ID: 9115096
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET appearance of pelvic Castleman's disease.
Murphy SP; Nathan MA; Karwal MW
J Nucl Med; 1997 Aug; 38(8):1211-2. PubMed ID: 9255152
[TBL] [Abstract][Full Text] [Related]
18. [Tumor diagnosis using 18F-FDG SPECT].
Sugiyama S; Suzuki Y; Matsuzaki H; Tomiyoshi K; Endo K
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Aug; 56(9):679-80. PubMed ID: 8831228
[TBL] [Abstract][Full Text] [Related]
19. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
[TBL] [Abstract][Full Text] [Related]
20. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]